2002
DOI: 10.1016/s0141-0229(02)00023-6
|View full text |Cite
|
Sign up to set email alerts
|

New yeast strains for enantioselective production of halohydrin precursor of (S)-Propranolol

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
5
0

Year Published

2002
2002
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(5 citation statements)
references
References 24 publications
0
5
0
Order By: Relevance
“…The PKS KRs were tested for their ability to catalyze the reduction of a number of commercially available ketones (Figure 3), which have been previously evaluated in biotransformation applications. For example, as the reduction of cyclohexanone has been used as a model system to identify reductases for more complex substrates,29 we chose to evaluate cyclohexanone and its derivatives (2 RS )‐allylcyclohexanone, 1,2‐cyclohexanedione, 1,3‐cyclohexanedione, (2 RS )‐methylcyclohexanone, and 4‐methylcyclohexanone, as well as cyclooctanone and cyclopentanone. There is also significant interest in enzymes that can reduce sterically crowded carbonyl centres30 (modelled here by dicyclohexyl ketone and the aromatic substrates 3‐ and 4‐methylacetophenone and propiophenone) and those capable of reducing very small substrates in a stereospecific fashion31 (investigated here with 2‐ketobutyric acid and ethyl vinyl ketone).…”
Section: Resultsmentioning
confidence: 99%
“…The PKS KRs were tested for their ability to catalyze the reduction of a number of commercially available ketones (Figure 3), which have been previously evaluated in biotransformation applications. For example, as the reduction of cyclohexanone has been used as a model system to identify reductases for more complex substrates,29 we chose to evaluate cyclohexanone and its derivatives (2 RS )‐allylcyclohexanone, 1,2‐cyclohexanedione, 1,3‐cyclohexanedione, (2 RS )‐methylcyclohexanone, and 4‐methylcyclohexanone, as well as cyclooctanone and cyclopentanone. There is also significant interest in enzymes that can reduce sterically crowded carbonyl centres30 (modelled here by dicyclohexyl ketone and the aromatic substrates 3‐ and 4‐methylacetophenone and propiophenone) and those capable of reducing very small substrates in a stereospecific fashion31 (investigated here with 2‐ketobutyric acid and ethyl vinyl ketone).…”
Section: Resultsmentioning
confidence: 99%
“…Some recent advances in the biocatalytic reduction of carbonyl-containing compounds are summarized in Table 1 (Additional file 1 ) and include for example the finding of new activities for Yarrowia lipolytica [ 56 ]. Lagos et al [ 56 ] screened different yeast strains for the enantioselective production of a halohydrin precursor for ( S )-propranolol synthesis. Yarrowia lipolytica 1240 (Spanish type culture collection CECT, Valencia) resting cells gave the 'anti-Prelog'-enantiomer ( S )-1-chloro-3-(1-naphthyloxy)propan-2-ol with 87% yield and 99% ee.…”
Section: Reviewmentioning
confidence: 99%
“…Furthermore, such a method is particularly advantageous in terms of cost-effectiveness, ease of preparation, and the ability to effectively perform several types of reactions [14]. Table 1 demonstrates the past application of whole cells of Y. lipolytica as a biocatalyst in various reactions, including hydrogenation, reduction, and oxidation [15][16][17][18][19][20][21][22][23][24][25][26][27][28][29].…”
Section: Whole-cell Biocatalysis With Y Lipolytica Cellsmentioning
confidence: 99%
“…Between 2000 and 2005, four different publications focused on reducing this ketone to 1-chloro-3-(1-naphthyloxy)propan-2-ol using various yeast species. The researchers found that the reduction of the ketone to alcohol with an S configuration occurred for Y. lipolytica strains with an efficiency ranging from 25 to 88% in 48 h reactions, and also showed higher yields than S. cerevisiae commonly used for this reaction [18][19][20][21]. Lagos et al [20] demonstrated also the possibility of using Y. lipolytica cells to obtain other compounds such as N-[4-[(S)-3-chloro-2-hydroxypropoxy]phenyl]acetamide, (S)-1-chloro-3-(2,5-dimethylphenoxy)propan-2-ol, and (S)-1chloro-3-phthalimidopropan-2-ol from the corresponding ketones.…”
Section: Substratementioning
confidence: 99%